ACHV
Price
$4.39
Change
-$0.14 (-3.09%)
Updated
Nov 14 closing price
118 days until earnings call
MPSYF
Price
$73.27
Change
-$0.00 (-0.00%)
Updated
Jul 9 closing price
Ad is loading...

ACHV vs MPSYF

Header iconACHV vs MPSYF Comparison
Open Charts ACHV vs MPSYFBanner chart's image
Achieve Life Sciences
Price$4.39
Change-$0.14 (-3.09%)
Volume$155.66K
CapitalizationN/A
MorphoSys AG
Price$73.27
Change-$0.00 (-0.00%)
Volume$3.5K
CapitalizationN/A
ACHV vs MPSYF Comparison Chart
Loading...
ACHV
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
View a ticker or compare two or three
VS
ACHV vs. MPSYF commentary
Nov 15, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ACHV is a Hold and MPSYF is a Hold.

COMPARISON
Comparison
Nov 15, 2024
Stock price -- (ACHV: $4.39 vs. MPSYF: $73.27)
Brand notoriety: ACHV and MPSYF are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ACHV: 147% vs. MPSYF: 100%
Market capitalization -- ACHV: $150.97M vs. MPSYF: $2.76B
ACHV [@Biotechnology] is valued at $150.97M. MPSYF’s [@Biotechnology] market capitalization is $2.76B. The market cap for tickers in the [@Biotechnology] industry ranges from $475.76B to $0. The average market capitalization across the [@Biotechnology] industry is $2.73B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ACHV’s FA Score shows that 0 FA rating(s) are green whileMPSYF’s FA Score has 1 green FA rating(s).

  • ACHV’s FA Score: 0 green, 5 red.
  • MPSYF’s FA Score: 1 green, 4 red.
According to our system of comparison, MPSYF is a better buy in the long-term than ACHV.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ACHV’s TA Score shows that 3 TA indicator(s) are bullish.

  • ACHV’s TA Score: 3 bullish, 7 bearish.

Price Growth

ACHV (@Biotechnology) experienced а -12.20% price change this week, while MPSYF (@Biotechnology) price change was 0.00% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -2.07%. For the same industry, the average monthly price growth was +3.27%, and the average quarterly price growth was +5.23%.

Reported Earning Dates

ACHV is expected to report earnings on Mar 13, 2025.

Industries' Descriptions

@Biotechnology (-2.07% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
MPSYF($2.76B) has a higher market cap than ACHV($151M). MPSYF YTD gains are higher at: 78.707 vs. ACHV (6.553).
ACHVMPSYFACHV / MPSYF
Capitalization151M2.76B5%
EBITDAN/AN/A-
Gain YTD6.55378.7078%
P/E RatioN/AN/A-
RevenueN/AN/A-
Total Cash1.24MN/A-
Total Debt17.2MN/A-
FUNDAMENTALS RATINGS
ACHV vs MPSYF: Fundamental Ratings
ACHV
MPSYF
OUTLOOK RATING
1..100
6450
VALUATION
overvalued / fair valued / undervalued
1..100
62
Fair valued
89
Overvalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
10098
PRICE GROWTH RATING
1..100
6042
P/E GROWTH RATING
1..100
10024
SEASONALITY SCORE
1..100
n/a50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

ACHV's Valuation (62) in the Biotechnology industry is in the same range as MPSYF (89) in the null industry. This means that ACHV’s stock grew similarly to MPSYF’s over the last 12 months.

ACHV's Profit vs Risk Rating (100) in the Biotechnology industry is in the same range as MPSYF (100) in the null industry. This means that ACHV’s stock grew similarly to MPSYF’s over the last 12 months.

MPSYF's SMR Rating (98) in the null industry is in the same range as ACHV (100) in the Biotechnology industry. This means that MPSYF’s stock grew similarly to ACHV’s over the last 12 months.

MPSYF's Price Growth Rating (42) in the null industry is in the same range as ACHV (60) in the Biotechnology industry. This means that MPSYF’s stock grew similarly to ACHV’s over the last 12 months.

MPSYF's P/E Growth Rating (24) in the null industry is significantly better than the same rating for ACHV (100) in the Biotechnology industry. This means that MPSYF’s stock grew significantly faster than ACHV’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
ACHV
RSI
ODDS (%)
N/A
Stochastic
ODDS (%)
Bullish Trend 1 day ago
69%
Momentum
ODDS (%)
Bearish Trend 1 day ago
87%
MACD
ODDS (%)
Bearish Trend 1 day ago
87%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
85%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
81%
Advances
ODDS (%)
Bullish Trend 10 days ago
0%
Declines
ODDS (%)
Bearish Trend 1 day ago
85%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
90%
Aroon
ODDS (%)
Bearish Trend 1 day ago
81%
View a ticker or compare two or three
Ad is loading...
ACHV
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
GME27.370.91
+3.44%
GameStop Corp
AAPL228.223.10
+1.38%
Apple
SPY593.35-3.84
-0.64%
SPDR® S&P 500® ETF Trust
BTC.X87250.430000-3333.734400
-3.68%
Bitcoin cryptocurrency
TSLA311.18-19.06
-5.77%
Tesla

ACHV and

Correlation & Price change

A.I.dvisor indicates that over the last year, ACHV has been closely correlated with HOFBF. These tickers have moved in lockstep 72% of the time. This A.I.-generated data suggests there is a high statistical probability that if ACHV jumps, then HOFBF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ACHV
1D Price
Change %
ACHV100%
-3.09%
HOFBF - ACHV
72%
Closely correlated
N/A
MPSYF - ACHV
34%
Loosely correlated
N/A
ACLX - ACHV
28%
Poorly correlated
-5.05%
BEAM - ACHV
27%
Poorly correlated
-4.33%
ARVN - ACHV
27%
Poorly correlated
-1.66%
More

MPSYF and

Correlation & Price change

A.I.dvisor indicates that over the last year, MPSYF has been loosely correlated with HOFBF. These tickers have moved in lockstep 41% of the time. This A.I.-generated data suggests there is some statistical probability that if MPSYF jumps, then HOFBF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MPSYF
1D Price
Change %
MPSYF100%
N/A
HOFBF - MPSYF
41%
Loosely correlated
N/A
ACHV - MPSYF
35%
Loosely correlated
-3.09%
QRON - MPSYF
32%
Poorly correlated
N/A
COGT - MPSYF
30%
Poorly correlated
-7.21%
MNPR - MPSYF
29%
Poorly correlated
-5.20%
More